Breaking News Instant updates and real-time market news.

AIG

AIG

$50.54

0.175 (0.35%)

, HSIC

Henry Schein

$66.89

3.75 (5.94%)

09:55
05/07/19
05/07
09:55
05/07/19
09:55

Early notable gainers among liquid option names on May 7th

Notable gainers among liquid option names this morning include AIG (AIG) $50.53 +3.46, Henry Schein (HSIC) $66.81 +3.50, FMC Corporation (FMC) $79.34 +3.10, Assurant (AIZ) $97.24 +3.30, and International Flavors (IFF) $140.01 +2.30.

AIG

AIG

$50.54

0.175 (0.35%)

HSIC

Henry Schein

$66.89

3.75 (5.94%)

FMC

FMC Corporation

$78.72

1.72 (2.23%)

AIZ

Assurant

$98.01

4.08 (4.34%)

IFF

International Flavors

$142.39

4.68 (3.40%)

  • 07

    May

  • 07

    May

  • 07

    May

  • 07

    May

  • 07

    May

  • 07

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 20

    Jun

AIG AIG
$50.54

0.175 (0.35%)

02/21/19
UBSW
02/21/19
NO CHANGE
Target $52
UBSW
Buy
AIG at inflection despite disappointing Q4 results, says UBS
UBS analyst Brian Meredith said despite AIG's disappointing Q4 results, management reiterated their expectation that the General Insurance segment would achieve a profit in Q1. The analyst also said the benefit coming from their reinsurance strategy in 2019 is underappreciated by the market. He believes management's guidance of margin expansion from a rate and mix shift will be challenging to achieve, so he modeled in half of the guidance only. Meredith maintained his Buy rating and $52 price target on AIG shares.
02/15/19
02/15/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Workday (WDAY) upgraded to Outperform from Market Perform at Cowen with analyst J. Derrick Wood saying his checks reveal a strong uptick in its pipeline of new blue chip Cloud financial customers and he believes it is ready to set off a new product cycle. 2. AIG (AIG) upgraded to Buy from Neutral at Compass Point. 3. Bloomin' Brands (BLMN) upgraded to Outperform from Market Perform at William Blair with analyst Sharon Zackfia saying he sees an "undemanding valuation" at current share levels as well as the potential for an operating margin recovery to add 200 basis points over the next three to four years. 4. Cedar Fair (FUN) upgraded to Outperform from Neutral at Macquarie. 5. Healthcare Trust (HTA) upgraded to Overweight from Equalweight at Capital One. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/15/19
ARGS
02/15/19
DOWNGRADE
ARGS
Hold
AIG downgraded to Hold from Buy at Argus
Argus analyst Jacob Kilstein downgraded AIG to Hold after its latest Q4 earnings miss driven by "catastrophe losses, large reserve charges, and poor investment results", saying the stock is consistently underperforming. The analyst believes that the company will continue to deal with "restructuring charges and higher-than-normal catastrophe losses", adding that while its price to book ratio of 0.6-times implies a discount to the peer industry average of 1.6-times, it is justified by its "below-average ROE and quarterly losses."
05/07/19
JPMS
05/07/19
NO CHANGE
Target $52
JPMS
Neutral
AIG results not as strong as first look suggests, says JPMorgan
JPMorgan analyst Jimmy Bhullar says that while AIG's Q1 results exceeded expectations, they are not as strong as they appear at first glance. Results were lifted by a few unusual items, primarily high investment income, Bhullar tells investors in a post-earnings research note. Further, as in recent quarters, net earnings was considerably below operating earnings, primarily due to high realized investment losses, adds the analyst. He affirms a Neutral rating on AIG with a $52 price target citing a "lackluster outlook" for business fundamentals and concerns about downside risk to consensus earnings forecasts.
HSIC Henry Schein
$66.89

3.75 (5.94%)

04/17/19
GUGG
04/17/19
INITIATION
GUGG
Buy
Henry Schein initiated with a Buy at Guggenheim
Guggenheim analyst Glen Santangelo initiated Henry Schein with a Buy rating and a $72 price target. The analyst believes the company can "continue to execute on its strategy, albeit at a slightly slower pace," after the spinoff, due to the "law of large numbers."
04/17/19
GUGG
04/17/19
INITIATION
Target $72
GUGG
Buy
Henry Schein initiated with a Buy at Guggenheim
Guggenheim initiated Henry Schein with a Buy and $72 price target.
05/02/19
CLVD
05/02/19
NO CHANGE
CLVD
Neutral
Cleveland Research still sees risk to Henry Schein's 2019 earnings
Cleveland Research analyst Rob Eich said his work suggests Q1 U.S. consumable sales were slightly softer than expected, driven by a slow start to the quarter, though he also notes signs that March and April rebounded somewhat. He believes Henry Schein's dental consumable margins declined 100-150 basis points in 2018 and he continues to see risk to its FY19 earnings due to persistent price and margin pressures, Eich told investors in a research note. He maintains a Neutral rating on Henry Schein shares.
03/25/19
BARD
03/25/19
NO CHANGE
Target $63
BARD
Neutral
Henry Schein price target raised to $63 from $59 at Baird
Baird analyst Jeff Johnson raised his price target on Henry Schein to $63 after hosting an investor lunch with management on Friday, telling investors that he came away believing the company remains well positioned to continue gaining share across both its dental and medical businesses and expanding its efforts in higher-margin software/services areas over time. The analyst maintains a Neutral rating, saying he doesn't see a high likelihood of upside to this year's EPS guidance, potentially keeping shares range bound in the upper $50s/low $60s over the next few quarters.
FMC FMC Corporation
$78.72

1.72 (2.23%)

04/18/19
RBCM
04/18/19
DOWNGRADE
RBCM
Sector Perform
FMC Corporation downgraded to Sector Perform from Outperform at RBC Capital
04/18/19
04/18/19
DOWNGRADE
Target $87

Sector Perform
FMC Corporation downgraded to Sector Perform at RBC Capital on valuation
As previously reported, RBC Capital analyst Arun Viswanathan downgraded FMC Corp to Sector Perform from Outperform and lowered his price target to $87 from $100 to reflect the "uncertainty of Rynaxypyr and Cyazypyr patent expiration" as well as the reduced multiple from the recent lithium separation. The analyst states however that the company has an "attractive" pipeline, free cash flow, and capital return plans to justify an above-peer multiple, concluding that the downgrade is also warranted by FMC Corp stock being "closer to fairly valued".
04/18/19
04/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Morgan Stanley (MS) downgraded to Neutral from Buy at Citi with analyst Keith Horowitz saying Morgan Stanley reported "strong" Q1 results but the shares are fairly valued. 2. Snap (SNAP) downgraded to Negative from Mixed at Vertical Group and to Neutral from Outperform at Wedbush. 3. Rite Aid (RAD) downgraded with a Sell from Neutral at Guggenheim while Walgreens Boots Alliance (WBA) was downgraded with a Neutral from Buy. 4. CF Industries (CF) downgraded to Underperform from Buy at BofA/Merrill with analyst Steve Byrne saying he has spoken with 10 key channel contacts in the Cornbelt and several commented that never in their 30-plus year careers have they seen fertilizer applications this far behind, mainly due to the weather. 5. FMC Corporation (FMC) downgraded to Sector Perform from Outperform at RBC Capital with analyst Arun Viswanathan citing the "uncertainty of Rynaxypyr and Cyazypyr patent expiration" as well as the reduced multiple from the recent lithium separation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/19
LOOP
04/12/19
NO CHANGE
Target $102
LOOP
Buy
FMC Corporation earnings forecast reduced at Loop Capital on weather disruptions
Loop Capital analyst Chris Kapsch is lowering his FY19 and FY20 EPS outlook for FMC Corp by 10c to $5.65 and $6.55 respectively, saying a more cautious stance is warranted by the "significant weather-driven disruption in North America" and the possibility of sourcing challenges from China becoming "more acute". In spite of these "transient" challenges, the analyst is keeping his Buy rating and $102 price target on the shares given its "transformational" deal with DuPont to become a "best-in-class Agriculture chemicals franchise", its "well-balanced global portfolio", and the "above-market organic growth prospects."
AIZ Assurant
$98.01

4.08 (4.34%)

07/11/18
RHCO
07/11/18
NO CHANGE
Target $129
RHCO
Buy
Assurant price target raised to $129 from $112 at SunTrust
SunTrust analyst Mark Hughes raised his price target on Assurant (AIZ) to $129 and kept his Buy rating, saying the company's operating environment within key end markets was generally healthy. Hughes notes that this should position the company to top consensus earnings for the quarter as it integrates TWG Holdings earlier than anticipated. The analyst also sees the valuation on Assurant as favorable given its post-integration expected run-rate earnings growth, stating that the company should "continue to outperform the broader smartphone industry" after a 18% expansion in devices covered during Q1 thanks to its emerging relationship with KDDI (KDDIY).
03/15/19
UBSW
03/15/19
NO CHANGE
Target $124
UBSW
Buy
Assurant price target lowered to $124 from $131 at UBS
UBS analyst John Nadel lowered his price target on Assurant to $124 after its Investor Day presentation, saying its outlook indicates that his prior assumptions for the company were "too aggressive". The analyst cites Assurant's affirmed earnings growth forecast of 6%-10% for FY19 and 12% in FY20-FY21, while he assumed 16% growth. Nadel also points to the company's shortfall that included lower cumulative buybacks and higher corporate loss but keeps his Buy rating on Assurant.
09/07/18
UBSW
09/07/18
NO CHANGE
Target $136
UBSW
Buy
Assurant price target raised to $136 from $118 at UBS
UBS analyst John Nadel raised his price target on Assurant to $136 from $118 despite lowering earnings estimates for 2018-2020. The analyst believes he factored in too large a contribution from the Warranty Group acquisition. He continues to view the risk/reward as very attractive with a 32% upside potential to his revised target. Nadel reiterated his Buy rating on Assurant shares.
07/16/18
KBWI
07/16/18
INITIATION
Target $121
KBWI
Outperform
Assurant initiated with an Outperform at Keefe Bruyette
Keefe Bruyette analyst Christopher Campbell started Assurant with an Outperform rating and $121 price target. The analyst sees share upside from the company's "solid" operating return on equity, better-than-peer dividend yield and increasing higher-multiple fee-based income.
IFF International Flavors
$142.39

4.68 (3.40%)

03/21/19
GSCO
03/21/19
UPGRADE
Target $151
GSCO
Buy
Goldman upgrades International Flavors to Buy on 'compelling entry point'
Goldman Sachs analyst Adam Samuelson last night upgraded International Flavors & Fragrances to Buy from Neutral and raised his price target for the shares to $151 from $137. With the shares down 8.7% year-to-date following the company's "disappointing" Q4 results and 2019 results, the stock now offers a "compelling entry point," Samuelson tells investors in a research note. The analyst believes International Flavors is "on the cusp" of a multi-year margin inflection, with the company reaching new peak EBITDA margins in 2021. He views International Flavors as a "high-quality defensive name" trading at an attractive valuation.
03/20/19
GSCO
03/20/19
UPGRADE
GSCO
Buy
International Flavors upgraded to Buy from Neutral at Goldman Sachs
02/25/19
KEYB
02/25/19
NO CHANGE
Target $143
KEYB
Overweight
International Flavors price target lowered to $143 from $160 at KeyBanc
KeyBanc analyst Michael Sison lowered his price target for International Flavors to $143 from $160 to reflect an updated 2019 outlook. The analyst reiterates an Overweight rating on the shares as he believes the Frutarom acquisition is a strong, long-term strategic fit. While he recognizes year one is weaker than expected, International Flavors should generate strong DD sales and EBITDA growth year over year with the Frutarom acquisition and LSD organic growth, Sison contends.
02/21/19
GHSC
02/21/19
INITIATION
GHSC
Neutral
International Flavors initiated with a Neutral at Seaport Global
Seaport Global analyst Brett Hundley initiated International Flavors with a Neutral rating citing aggressive debt retirement assumptions and valuation.

TODAY'S FREE FLY STORIES

TEVA

Teva

$10.86

-0.18 (-1.63%)

12:11
05/26/19
05/26
12:11
05/26/19
12:11
Hot Stocks
Teva reaches $85M agreement with State of Oklahoma »

Teva Pharmaceuticals USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESLT

Elbit Systems

$141.85

1.33 (0.95%)

12:08
05/26/19
05/26
12:08
05/26/19
12:08
Hot Stocks
Elbit Systems awarded $127M contract to provide tactical radio system »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ADM

Archer Daniels

$39.17

-0.03 (-0.08%)

12:05
05/26/19
05/26
12:05
05/26/19
12:05
Hot Stocks
Archer Daniels expands recall of Baker's Corner All Purpose Flour 5lb bags »

ADM Milling is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

JCP

J.C. Penney

$0.93

0.022 (2.42%)

, DDS

Dillard's

$56.57

0.25 (0.44%)

13:29
05/25/19
05/25
13:29
05/25/19
13:29
Periodicals
Target stock triumphs in brutal week for retail, Barron's says »

Earnings season has been…

JCP

J.C. Penney

$0.93

0.022 (2.42%)

DDS

Dillard's

$56.57

0.25 (0.44%)

KSS

Kohl's

$51.11

-0.04 (-0.08%)

JWN

Nordstrom

$33.50

-0.31 (-0.92%)

M

Macy's

$21.00

-0.27 (-1.27%)

TGT

Target

$81.57

2.17 (2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

JPM

JPMorgan

$109.78

1.14 (1.05%)

, AKZOY

AkzoNobel

$0.00

(0.00%)

13:24
05/25/19
05/25
13:24
05/25/19
13:24
Periodicals
Microsoft, JPMorgan among dividend champions, Barron's says »

Among the companies that…

JPM

JPMorgan

$109.78

1.14 (1.05%)

AKZOY

AkzoNobel

$0.00

(0.00%)

XOM

Exxon Mobil

$74.12

0.33 (0.45%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

CMWAY

Commonwealth Bank of Australia

$0.00

(0.00%)

SIEGY

Siemens

$0.00

(0.00%)

T

AT&T

$32.29

0.15 (0.47%)

RDS.A

Royal Dutch Shell

$63.29

0.84 (1.35%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$87.49

3.03 (3.59%)

BHP

BHP Group

$52.47

1.18 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 29

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 05

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 11

    Jun

  • 12

    Jun

  • 20

    Jun

  • 23

    Jun

  • 16

    Jul

  • 24

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

GM

General Motors

$35.13

0.01 (0.03%)

, TSLA

Tesla

$190.80

-4.7 (-2.40%)

13:19
05/25/19
05/25
13:19
05/25/19
13:19
Periodicals
Tesla stock in trouble, Barron's says »

Tesla (TSLA) stock is the…

GM

General Motors

$35.13

0.01 (0.03%)

TSLA

Tesla

$190.80

-4.7 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

  • 11

    Jun

  • 01

    Aug

RNLSY

Renault

$0.00

(0.00%)

13:14
05/25/19
05/25
13:14
05/25/19
13:14
Periodicals
Renault stock may rally, Barron's says »

Shares of French auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

, DWDP

DowDuPont

$31.10

0.16 (0.52%)

13:11
05/25/19
05/25
13:11
05/25/19
13:11
Periodicals
DowDuPont spinoff a new agriculture stock, FMC safer bet, Barron's says »

The crop-protection and…

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

DWDP

DowDuPont

$31.10

0.16 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 25

    Jun

MGM

MGM Resorts

$25.55

0.19 (0.75%)

13:03
05/25/19
05/25
13:03
05/25/19
13:03
Periodicals
MGM Resorts looks like an attractive gambling play, Barron's says »

MGM Resorts (MGM) stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

PYPL

PayPal

$109.82

-0.09 (-0.08%)

, AXP

American Express

$119.52

1.07 (0.90%)

12:30
05/25/19
05/25
12:30
05/25/19
12:30
Periodicals
Big tech failed to dethrone credit cards, Barron's says »

Rather than being cut out…

PYPL

PayPal

$109.82

-0.09 (-0.08%)

AXP

American Express

$119.52

1.07 (0.90%)

MA

MasterCard

$251.40

1.57 (0.63%)

V

Visa

$162.72

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 06

    Jun

  • 11

    Jun

  • 25

    Jun

  • 13

    Nov

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

, GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

07:20
05/25/19
05/25
07:20
05/25/19
07:20
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

AMBA

Ambarella

$38.28

1.07 (2.88%)

ON

ON Semiconductor

$17.68

-0.235 (-1.31%)

NKE

Nike

$82.12

-0.51 (-0.62%)

ADDYY

Adidas

$0.00

(0.00%)

UAA

Under Armour

$23.54

0.075 (0.32%)

UA

Under Armour

$20.91

0.08 (0.38%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

VMC

Vulcan Materials

$126.28

1.25 (1.00%)

FLR

Fluor

$29.04

0.18 (0.62%)

ACM

Aecom

$31.56

-0.03 (-0.09%)

X

U.S. Steel

$13.63

-0.08 (-0.58%)

AKS

AK Steel

$2.00

-0.155 (-7.21%)

NUE

Nucor

$51.12

-0.27 (-0.53%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$12.85

0.11 (0.86%)

F

Ford

$9.83

-0.02 (-0.20%)

GM

General Motors

$35.13

0.01 (0.03%)

HMC

Honda

$25.45

0.175 (0.69%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$118.54

1.16 (0.99%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

  • 03

    Jun

  • 04

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 23

    Jun

  • 09

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.